Clinical Trial Update: Photodynamic Therapy With PD P 506 A Compared With Placebo-PDT for the Treatment of AK [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Photodynamic Therapy with PDP-506A to placebo-PDT for actinic keratosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• PDP-506A (PDP-506A)

Snippet

Sponsor: photonamic GmbH & Co. KG | Conditions: Actinic Keratosis | Phase 3 | Status: COMPLETED